Neurocrine Biosciences
NBIX
#1581
Rank
C$15.38 B
Marketcap
$154.30
Share price
-3.40%
Change (1 day)
-17.45%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of December 2024 : C$3.73 Billion

According to Neurocrine Biosciences 's latest financial reports the company has C$3.73 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$C$3.71 B25.53%
2023-12-31$C$2.96 B27.75%
2022-12-31$C$2.31 B32.34%
2021-12-31$C$1.75 B21.94%
2020-12-31$C$1.43 B72.63%
2019-12-31$C$0.83 B27.02%
2018-12-31$C$0.65 B39.97%
2017-12-31$C$0.46 B10.57%
2016-12-31$C$0.42 B-28.13%
2015-12-31$C$0.58 B143.11%
2014-12-31$C$0.24 B88.95%
2013-12-31$C$0.12 B-16.5%
2012-12-31$C$0.15 B151.18%
2011-12-31$C$61.11 M216.04%
2010-12-31$C$19.33 M364.79%
2009-12-31$C$4.16 M-90.7%
2008-12-31$C$44.71 M-62.24%
2007-12-31$C$0.11 B-67.68%
2006-12-31$C$0.36 B-19.32%
2005-12-31$C$0.45 B-3.98%
2004-12-31$C$0.47 B-6.77%
2003-12-31$C$0.50 B43.25%
2002-12-31$C$0.35 B-28.37%
2001-12-31$C$0.49 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$2.90 B-22.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.90 B 299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-C$9.2 Million-100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.56 B 451.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.84 B 29.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$127.50 B 3,317.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.61 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$52.44 Million-101.41%๐Ÿ‡บ๐Ÿ‡ธ USA